In-vivo dose verification in brachytherapy requires a small insertable dosimeter with a real time readout capability. Fibre optic scintillation dosimeters, consisting of a plastic scintillator coupled to an optical fibre, are one of the most promising dosimeters for this application. We have developed two BrachyFOD™ scintillation dosimeters with a fibre and scintillator diameter of 0.5 and 1 mm (Figure 1) . Results are compared with a Thompson and and a PTW-Freiburg type 60003pdw diamond detector. Nielson RD502 MOSFET
Introduction:
In-vivo dose verification in brachytherapy requires a small insertable dosimeter with a real time readout capability. Fibre optic scintillation dosimeters, consisting of a plastic scintillator coupled to an optical fibre, are one of the most promising dosimeters for this application. We have developed two BrachyFOD™ scintillation dosimeters with a fibre and scintillator diameter of 0.5 and 1 mm (Figure 1) Ir source. The activity of the source over the ten weeks was between 10Ci and 5Ci.
Figure 1. BrachyFOD™s and other dosimeters of comp

Results:
The BrachyFOD™ was found to be the most sensitive dete The angular dependence was within 2%, which is better than the MOSFET and comparable with the diamond detector, and is small enough for insertion into a 2 mm catheter, unlike the commercially available detectors. The background signal created by Cerenkov and fibre fluorescence does not significantly affect the performance in most clinical geometries using an 192 Ir from an HDR unit.
Conclusion:
The small size and flexibility of the Brac suitable for in-vivo intraluminal insertion. The small detector volume ensures the high spatial resolution needed for the high dose gradients in brachytherapy. The BrachyFOD™ has a high signal to noise ratio enabling accurate dose rate total dose readings in real time up to distances of 250 mm from the HDR source.
